We are live on ! Find out more
NAM

Needelman Asset Management Portfolio holdings

AUM $46M
1-Year Est. Return 8.27%
This Fund
S&P 500
This Quarter Est. Return
+2.23%
1 Year Est. Return
+8.27%
3 Year Est. Return
+30.52%
5 Year Est. Return
+74.86%
10 Year Est. Return
–
AUM
$32.9M
AUM Growth
+$316K
Cap. Flow
-$103K
Cap. Flow %
-0.31%
Top 10 Hldgs %
39.77%
Holding
37
New
–
Increased
5
Reduced
27
Closed
–

Top Buys

Rank Stock Value
1
INTC icon
Intel
INTC
+$2.53K
2
KMB icon
Kimberly-Clark
KMB
+$2.21K
3
GE icon
GE Aerospace
GE
+$1.43K
4
T icon
AT&T
T
+$1.17K
5
ETP
Energy Transfer Partners L.p.
ETP
+$593

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$11K
2
ELV icon
Elevance Health
ELV
+$10.7K
3
CB
CHUBB CORPORATION
CB
+$7.59K
4
MKL icon
Markel Group
MKL
+$7.23K
5
BAC icon
Bank of America
BAC
+$6.67K

Sector Composition

Rank Sector Weight
1 Healthcare 28.2%
2 Financials 22.79%
3 Technology 12.06%
4 Industrials 10.47%
5 Consumer Staples 9.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.54T
$1.65M 5%
52,944
-140
-0.3% -$4.23K
UNH icon
2
UnitedHealth
UNH
$376B
$1.54M 4.69%
13,055
-40
-0.3% -$4.44K
ELV icon
3
Elevance Health
ELV
$81.5B
$1.47M 4.47%
9,540
-75
-0.8% -$10.7K
MKL icon
4
Markel Group
MKL
$23.3B
$1.43M 4.34%
1,860
-10
-0.5% -$7.23K
HON icon
5
Honeywell
HON
$77B
$1.3M 3.94%
13,839
– –
BAC icon
6
Bank of America
BAC
$435B
$1.16M 3.52%
75,336
-415
-0.5% -$6.67K
JNJ icon
7
Johnson & Johnson
JNJ
$618B
$1.16M 3.51%
11,490
-5
-0% -$508
TEVA icon
8
Teva Pharmaceuticals
TEVA
$40.8B
$1.15M 3.48%
18,425
-50
-0.3% -$2.91K
BRK.B icon
9
Berkshire Hathaway Class B
BRK.B
$1.1T
$1.13M 3.42%
7,805
– –
PFE icon
10
Pfizer
PFE
$143B
$1.12M 3.41%
34,033
-110
-0.3% -$3.5K
INTC icon
11
Intel
INTC
$455B
$1.09M 3.31%
34,832
+75
+0.2% +$2.53K
JPM icon
12
JPMorgan Chase
JPM
$935B
$1.08M 3.29%
17,873
-70
-0.4% -$4.14K
AON icon
13
Aon
AON
$76.5B
$1.01M 3.08%
10,560
-40
-0.4% -$3.87K
YUM icon
14
Yum! Brands
YUM
$41.8B
$1.01M 3.07%
17,902
– –
PG icon
15
Procter & Gamble
PG
$336B
$954K 2.9%
11,646
-70
-0.6% -$6.02K
BMY icon
16
Bristol-Myers Squibb
BMY
$133B
$934K 2.83%
14,480
-175
-1% -$11K
CB
17
DELISTED
CHUBB CORPORATION
CB
$928K 2.82%
9,175
-75
-0.8% -$7.59K
QCOM icon
18
Qualcomm
QCOM
$155B
$872K 2.65%
12,580
-35
-0.3% -$2.47K
KMB icon
19
Kimberly-Clark
KMB
$36.3B
$825K 2.5%
7,698
+20
+0.3% +$2.21K
PEG icon
20
Public Service Enterprise Group
PEG
$38.2B
$812K 2.46%
19,380
– –
MRK icon
21
Merck
MRK
$322B
$794K 2.41%
14,483
-42
-0.3% -$2.38K
DEO icon
22
Diageo
DEO
$49B
$771K 2.34%
6,969
-20
-0.3% -$2.3K
WFC icon
23
Wells Fargo
WFC
$261B
$768K 2.33%
14,116
-70
-0.5% -$3.78K
EMR icon
24
Emerson Electric
EMR
$83.9B
$756K 2.29%
13,355
-50
-0.4% -$2.91K
GE icon
25
GE Aerospace
GE
$374B
$718K 2.18%
6,040
+12
+0.2% +$1.43K
1
2

Similar funds

PRHC
P.R. Herzig & Co Roslyn Heights, New York $45.9M AUM 15.88% 1-Year Est. Return
BC
Breogan Capital New York $56.4M AUM
SCPM
Social Capital PEP Management Palo Alto, California $56.5M AUM
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
BCP
Blum Capital Partners San Francisco, California $34.1M AUM 1.14% 1-Year Est. Return
AVA
Accel VIII Associates Palo Alto, California $65.1M AUM
GG
Gores Group Beverly Hills, California $22.3M AUM 4.58% 1-Year Est. Return
SM
SLS Management New York $17.2M AUM 14.82% 1-Year Est. Return

Needelman Asset Management's Q1 2015 Portfolio in Review

As of Q1 2015, Needelman Asset Management held 37 positions worth $32.9M, up 0.97% from $32.6M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Trading was light in Q1 2015: portfolio turnover was 0%. Needelman Asset Management opened no new positions and made no exits, leaving the 37-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Financials and Technology.

  • Needelman Asset Management added most to Intel in Q1 2015, an estimated $2.53K increase.
  • Needelman Asset Management's biggest Q1 2015 reduction was Bristol-Myers Squibb, cutting an estimated $11K.
  • Needelman Asset Management's ten largest holdings make up 40% of its $32.9M portfolio in Q1 2015.
  • Needelman Asset Management opened 0 new positions and closed 0 in Q1 2015.
  • Needelman Asset Management's portfolio value rose 0.97% quarter-over-quarter to $32.9M.

Based on Needelman Asset Management's 13F filing for Q1 2015, filed 9 Apr 2015.